Feasibility study of personalized peptide vaccination for recurrent ovarian cancer patients.
Kawano K, Tsuda N, Matsueda S, Sasada T, Watanabe N, Ushijima K, Yamaguchi T, Yokomine M, Itoh K, Yamada A, Kamura T.
Kawano K, et al. Among authors: tsuda n.
Immunopharmacol Immunotoxicol. 2014 Jun;36(3):224-36. doi: 10.3109/08923973.2014.913617. Epub 2014 Apr 29.
Immunopharmacol Immunotoxicol. 2014.
PMID: 24773550
Clinical Trial.